Award recordCONTRACT

CSL BEHRING L.L.C.

PIID 36C24724F0143· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· Q517 · PHARMACY SERVICES· FY2024· $116,557 net obligations· UEI H3WKVE9VBLY3· PA

Description

HAEGARDA INJECTIONS

First action · last action
2023-12-04 · 2024-11-27
Transactions
2
First transaction's obligation
$136,200
Base + all options value (sum of deltas)
$116,557
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79721D0249
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$136,200$0Base award · 2023-12-04 · this action $136,200 · running total $136,200Modification P00001 · 2024-11-27 · this action -$19,643 · running total $116,557
  • Base2023-12-04+$136,200= $136,200
  • Mod P000012024-11-27-$19,643= $116,557
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-12-04+$136,200$136,200HAEGARDA INJECTIONS
Mod P00001· FUNDING ONLY ACTION2024-11-27−$19,643$116,557HAEGARDA INJECTIONS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under Q517 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0615PHARMALINK INC247-NETWORK CONTRACT OFFICE 7 (36C247)$20,400FY2026
36C24726P0429CARDINAL HEALTH 414, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$24,000FY2026
36C24726F0046MINBURN TECHNOLOGY GROUP, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$147,618FY2026
36C24726F0260NOVARTIS PHARMACEUTICALS CORPORATION247-NETWORK CONTRACT OFFICE 7 (36C247)$0FY2026
36C24725P0955ICP HOLDINGS, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$38,000FY2025

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24724F0143_3600_36F79721D0249_3600 · retrieved 2026-09-26.